Clinical Trial: An Observational Study on Epithelioid Sarcoma
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Observational
Official Title: Epithelioid Sarcoma. An Observational Study
Brief Summary: Prospective Italian study aimed to provide a description of the population affected by Epithelioid Sarcoma (ES)
Detailed Summary: The present prospective national study aims to provide a description of the population affected by ES, an insight into the natural history of the disease and an answer some on the outstanding questions on its management. Also, it will focus on enhancing any differences between the two ES variants (classical-type and proximal-type) in order gain a better understanding of the disease, tailor the treatment and lastly improve outcome.
Sponsor: Italian Sarcoma Group
Current Primary Outcome: Type of treatment given to patients with ES [ Time Frame: From diagnosis until the date of death from any cause assessed up to 60 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Radiotherapy treatments [ Time Frame: From the time of diagnosis and then every 6 months up to 60 months ]Number of patients affected by localized ES who received radiotherapy
- Chemotherapy treatments [ Time Frame: From the time of diagnosis and then every 6 months up to 60 months ]Number of patients affected by localized ES who received chemotherapy
- Predictive biomarkers for response [ Time Frame: At time of diagnosis and at the time of any progression where a biopsy is performed up to 60 months ]Tumor biomarkers expression in tumor tissue of patients affected by ES
Original Secondary Outcome: Same as current
Information By: Italian Sarcoma Group
Dates:
Date Received: March 17, 2017
Date Started: May 1, 2017
Date Completion: December 1, 2020
Last Updated: March 28, 2017
Last Verified: March 2017